172 related articles for article (PubMed ID: 26331584)
21. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
22. Silk fibroin nanoparticles for cellular uptake and control release.
Kundu J; Chung YI; Kim YH; Tae G; Kundu SC
Int J Pharm; 2010 Mar; 388(1-2):242-50. PubMed ID: 20060449
[TBL] [Abstract][Full Text] [Related]
23. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
[TBL] [Abstract][Full Text] [Related]
24. Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin.
Qu J; Liu Y; Yu Y; Li J; Luo J; Li M
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():166-74. PubMed ID: 25280693
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
26. Coaxial electrospun aligned tussah silk fibroin nanostructured fiber scaffolds embedded with hydroxyapatite-tussah silk fibroin nanoparticles for bone tissue engineering.
Shao W; He J; Sang F; Ding B; Chen L; Cui S; Li K; Han Q; Tan W
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():342-51. PubMed ID: 26478319
[TBL] [Abstract][Full Text] [Related]
27. Intracellularly monitoring/imaging the release of doxorubicin from pH-responsive nanoparticles using Förster resonance energy transfer.
Chen KJ; Chiu YL; Chen YM; Ho YC; Sung HW
Biomaterials; 2011 Apr; 32(10):2586-92. PubMed ID: 21251711
[TBL] [Abstract][Full Text] [Related]
28. Cationic core-shell liponanoparticles for ocular gene delivery.
Jiang M; Gan L; Zhu C; Dong Y; Liu J; Gan Y
Biomaterials; 2012 Oct; 33(30):7621-30. PubMed ID: 22789720
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
30. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery.
Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B
ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601
[TBL] [Abstract][Full Text] [Related]
31. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
[TBL] [Abstract][Full Text] [Related]
33. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.
Nafee N; Schneider M; Schaefer UF; Lehr CM
Int J Pharm; 2009 Nov; 381(2):130-9. PubMed ID: 19450671
[TBL] [Abstract][Full Text] [Related]
34. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
35. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
[TBL] [Abstract][Full Text] [Related]
36. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-loaded silk fibroin nanospheres.
Chen M; Shao Z; Chen X
J Biomed Mater Res A; 2012 Jan; 100(1):203-10. PubMed ID: 22021221
[TBL] [Abstract][Full Text] [Related]
38. Chitosan-ceramide coating on gold nanorod to improve its physiological stability and reduce the lipid surface-related toxicity.
Battogtokh G; Gotov O; Ko YT
Arch Pharm Res; 2017 Mar; 40(3):356-363. PubMed ID: 28078525
[TBL] [Abstract][Full Text] [Related]
39. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery.
Bao H; Pan Y; Ping Y; Sahoo NG; Wu T; Li L; Li J; Gan LH
Small; 2011 Jun; 7(11):1569-78. PubMed ID: 21538871
[TBL] [Abstract][Full Text] [Related]
40. Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles.
Lee AL; Wang Y; Ye WH; Yoon HS; Chan SY; Yang YY
Biomaterials; 2008 Mar; 29(9):1224-32. PubMed ID: 18078986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
